MGI MP annotations for MGI:2443306: Tom1l2

  • Gray arrows indicate "is_a"



    Compare annotations to MP categories for MGI:2443306.
    IDTermTom1l2Gt(XG909)Byg
    MP:0005386behavior/neurological phenotypeTom1l2Gt(XG909)Byg
    MP:0005385cardiovascular system phenotypeTom1l2Gt(XG909)Byg
    MP:0005382craniofacial phenotypeTom1l2Gt(XG909)Byg
    MP:0005397hematopoietic system phenotypeTom1l2Gt(XG909)Byg
    MP:0005387immune system phenotypeTom1l2Gt(XG909)Byg
    MP:0010771integument phenotypeTom1l2Gt(XG909)Byg
    MP:0003631nervous system phenotypeTom1l2Gt(XG909)Byg
    MP:0005367renal/urinary system phenotypeTom1l2Gt(XG909)Byg
    MP:0005390skeleton phenotypeTom1l2Gt(XG909)Byg
    MP:0002006tumorigenesisTom1l2Gt(XG909)Byg
    MP:0005391vision/eye phenotypeTom1l2Gt(XG909)Byg


    Full set of annotations for MGI:2443306
    IDTermAlleleAllelesBackgroundColor Key
    MP:0002065abnormal fear/anxiety-related behavior Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001800abnormal humoral immune response Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001790abnormal immune system physiology Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001845abnormal inflammatory response Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008828abnormal lymph node cell ratio Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008470abnormal spleen B cell follicle morphology Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0000689abnormal spleen morphology Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0002358abnormal spleen periarteriolar lymphoid sheath morphology Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008826abnormal splenic cell ratio Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0004208basal cell carcinoma Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001852conjunctivitis Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0003179decreased platelet cell number Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001194dermatitis Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0000691enlarged spleen Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0000418focal hair loss Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001914hemorrhage Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001891hydroencephaly Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0005014increased B cell number Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008074increased CD4-positive T cell number Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008078increased CD8-positive T cell number Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0005015increased T cell number Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0010383increased adenoma incidence Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001846increased inflammatory response Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0000218increased leukocyte cell number Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008014increased lung tumor incidence Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0010299increased mammary gland tumor incidence Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001272increased metastatic potential Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008000increased ovary tumor incidence Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0010357increased prostate gland tumor incidence Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0010300increased skin tumor incidence Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0008478increased spleen white pulp amount Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0002412increased susceptibility to bacterial infection Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0002406increased susceptibility to infection Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0002020increased tumor incidence Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0003675kidney cysts Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0000160kyphosis Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0000688lymphoid hyperplasia Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0000120malocclusion Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001212skin lesions Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key
    MP:0001209spontaneous skin ulceration Tom1l2Gt(XG909)Byg Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byginvolves: 129P2/OlaHsd * C57BL/6Jcolor key